Good post ring, The beauty about biomedical companies is that...

Good post ring,

The beauty about biomedical companies is that you never know who is watching and what triggers investors to take a large stake in the company.

For me. once the rights issue is out of the way, fully underwritten of course, SBN then has the funds and the management team to attract many suitors.
In my opinion I think the scenario will play out like this. Copy and paste it back to me if you like.

Rights issue to be announced very soon, there was a board meeting today, fully underwritten by xxxxxx stock broking firm. Strike price 1.5c and a 2 for 1 issue. Aim is to raise $3 mil by placing 200 mil shares.

Record date approximately a week after it is announced.

During that time I believe we will have a substantial announcement which will force the price into the mid 2c and further upward pressure could push the sp higher depending on how many have to scamble to purchase shares in order to qualify for their issue.

From there we have a great business model and one that is fully funded. the sp could then move very rapidly as the company is re-rated.

You may ask what I think the announcement is, well I agree with Vin.